Trial Search Results
Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
The investigators study is to investigate safety and efficacy of performing a planned incomplete removal of large acoustic neuroma tumors to decrease surgical morbidity and yet avoid tumor recurrence by post-operative radiation therapy.
Stanford is currently accepting patients for this trial.
Collaborator: Louisiana State University Health Sciences Center in New Orleans
- Procedure: Microsurgery
- Procedure: Stereotactic radiation therapy
- Adult patients with acoustic neuromas the widest diameter of 2.5 cm or larger at the
cerebellopontine angle are eligible for this trial.
- Patients that are deemed good surgical candidates based on age, general health,
genetic predispositions, and hearing in contralateral side would be included as the
subjects of this trial.
- Although we would include patients with neurofibromatosis II in this trial,
considering their genetic predisposition for recurrence, we would analyze their
outcome as a separate group.
- Patients who have received any form of treatment of their acoustic neuromas prior to
enrollment in the study including surgery or radiation therapy.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study